Notice - Prescription Drug List (PDL): Mometasone furoate (English, HTML)

View metadata and access the original English HTML file: Notice - Prescription Drug List (PDL): Mometasone furoate.

Format

HTML

Access

file-only

Publisher-reported update

2023-09-29

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to allow the nonprescription use of Mometasone furoate for the conditions listed below. Only the Human part of the PDL was revised.

Access original file